Brief: Biotech BB Says 2022 Net Loss At CHF 358 Mln

Bb Biotech

20/01/2023 06:07

Jan 20 (Reuters) - BB Biotech AG  BION.S :
    * DIVERGENT BIOTECH EQUITY MARKETS MIRROR VALUE OVER GROWTH
THEME
IN 2022 – PROPOSED DIVIDEND OF CHF 2.85
    * NET LOSS FOR BB BIOTECH IN 2022 WAS CHF 358 MN
    * Q4 NET LOSS OF CHF 35 MN COMPARED TO NET LOSS OF CHF 546
MN FOR
Q4 2021
    * DURING Q4, INVESTMENT TEAM MADE NO NEW INVESTMENTS, BUT
ADDED TO
EXISTING PORTFOLIO POSITIONS

Source text for Eikon:  ID:nEQ520hxra 
Further company coverage:  BION.S 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))